What is the current Price Target for the Pharvaris NV stock?

The average Pharvaris NV target price is $33.15. This is 53.54% higher than the current stock price. The highest price target is 191.80%, the lowest is 26.31%. 14 Analysts have issued a price target Pharvaris NV 2026 .

How high will the Pharvaris NV stock rise?

No reliable answer can be given as to how high the Pharvaris NV stock will rise. The performance of stocks, including the Pharvaris NV stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Pharvaris NV stock today?

The performance of Pharvaris NV stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Pharvaris NV stock fall?

The decline in Pharvaris NV stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Pharvaris NV Forecast, price target & analysts

$21.59

0.96% yesterday

Nasdaq, Nov 07, 10:00 pm CET

ISIN

NL00150005Y4

Symbol

PHVS

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Pharvaris NV Target price 2025 - Analyst rating & recommendation

Pharvaris NV Classifications & Recommendation:

Buy

89%

Hold

11%

Pharvaris NV Price Target

Target Price	$33.15
Price	$21.59
Potential	53.54% register free of charge
Number of Estimates	14

	14 Analysts have issued a price target Pharvaris NV 2026 . The average Pharvaris NV target price is $33.15. This is 53.54% register free of charge higher than the current stock price. The highest price target is $63.00 191.80% register free of charge , the lowest is $27.27 26.31% register free of charge .
	A rating was issued by 18 analysts: 16 Analysts recommend Pharvaris NV to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Pharvaris NV stock has an average upside potential 2026 of 53.54% register free of charge . Most analysts recommend the Pharvaris NV stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.87	-3.32
	5.59%	15.68%
P/E		negative

13 Analysts have issued a Pharvaris NV forecast for earnings per share. The average Pharvaris NV EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.87	5.59%
2025	$-3.32 15.68% Unlock
2026	$-3.23 2.71% Unlock
2027	$-2.36 26.93% Unlock
2028	$-0.75 68.22% Unlock
2029	$1.56 308.00% Unlock
2030	$4.31 176.28% Unlock
2031	$8.89 106.26% Unlock
2032	$10.96 23.28% Unlock

Current	-6.03	31.33%
2025	-6.50 7.78% Unlock
2026	-6.68 2.77% Unlock
2027	-9.15 36.98% Unlock
2028	-28.68 213.44% Unlock
2029	13.83 148.22% Unlock
2030	5.01 63.77% Unlock
2031	2.43 51.50% Unlock
2032	1.97 18.93% Unlock

Pharvaris NV...

Current Pharvaris NV Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 15 2025
B of A Securities	Locked ➜ Locked	Locked	Oct 09 2025
JMP Securities	Locked ➜ Locked	Locked	Aug 13 2025
Wedbush	Locked ➜ Locked	Locked	Jun 05 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	May 14 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	Apr 29 2025
Citizens Capital Markets	Locked ➜ Locked	Locked	Mar 03 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 15 2025
Locked B of A Securities: Locked ➜ Locked	Oct 09 2025
Locked JMP Securities: Locked ➜ Locked	Aug 13 2025
Locked Wedbush: Locked ➜ Locked	Jun 05 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	May 14 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	Apr 29 2025
Locked Citizens Capital Markets: Locked ➜ Locked	Mar 03 2025

Discover more stocks with a high price target

Novo Nordisk 60.25%

TUI 59.01%

Adidas 53.11%

Deutsche Telekom 45.39%

Meta Platforms (Facebook) 43.56%

Adyen 39.97%

BYD 38.89%

BioNTech SE - ADR 34.99%

Coinbase Global, Inc. 33.30%

Infineon 30.91%

Microsoft 29.34%

Netflix 28.46%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now